NCI Definition: A malignant melanoma within the conjunctiva of the eye. 
Conjunctival melanomas most frequently harbor alterations in TP53, NRAS, PTPN11, NTRK1, and GRIN2A .
TP53 c.217-c.1178 Missense, TP53 Mutation, TP53 Missense, NRAS Mutation, and NRAS Exon 3 Mutation are the most common alterations in conjunctival melanoma .
There is 1 clinical trial for conjunctival melanoma, of which 1 is open and 0 are completed or closed. Of the trial that contains conjunctival melanoma as an inclusion criterion, 1 is phase 2 (1 open).
Avadomide and nivolumab are the most common interventions in conjunctival melanoma clinical trials.
2. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 8. This dataset does not represent the totality of the genetic landscape; see paper for more information.